Dr. Aisling Barry completed her MB, Bch degree at Trinity College Dublin in 2005, and obtained her MRCPI’s in 2008 and Fellowship in Radiation Oncology in Dublin in 2014. This was followed by additional training as a Clinical and Research Fellow at the Princess Margaret Cancer Centre, Toronto, with emphasis on Breast, Lung, and GI malignancies, from 2014-2016.  During this time, Dr. Barry acquired significant expertise in stereotactic radiotherapy treatments for lung and liver tumors.  She was appointed as an Assistant Professor in the Department of Radiation Oncology at Princess Margaret Cancer Centre and the University of Toronto in 2017. Dr.  Barry has received several competitive awards, including the 20th Annual Lynn Sage Breast Cancer Symposium Travel Award in 2018, the prestigious Conquer Cancer Foundation of American Society of Clinical Oncology Merit Award in 2016 and a Dr. Richard Stevens bursary in 2015. Her current research areas of interest include the use of SBRT in oligo-progressive and oligo-metastatic disease and in early stage breast cancer.